Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Discover high-quality research tools to investigate GLP-1 mechanisms and next-generation metabolic targets.
OBESITY RESEARCH SOLUTIONSPhenylarsine oxide is an organoarsenic compound.1 It inhibits insulin-induced protein phosphatase 1 (PP1) activity and glucose transporter 4 (Glut4) translocation in rat adipocytes when used at a concentration of 5 µM. Phenylarsine oxide completely inhibits insulin-induced PI3K activation and glucose transport in 3T3-L1 adipocytes when used at concentrations of 30 and 50 µM, respectively.2 It inhibits potassium chloride-induced exocytosis and induces mitochondrial depolarization in isolated rat brain synaptosomes.3 Phenylarsine oxide (0.3 and 1 mg/kg, i.p.) reduces LPS-induced neutrophil infiltration in bronchoalveolar lavage fluid (BALF) and carrageenan-induced paw edema in rats.4
WARNING This product is not for human or veterinary use.
1. Phenylarsine oxide inhibits insulin-
2. Phenylarsine oxide inhibits insulin activation of phosphatidylinositol 3'-
3. Phenylarsine oxide is able to dissipate synaptic vesicle acidic pool. Neurochem. Int. 46(7), 541-550 (2005).
4. Neutrophil-